Illinois Bone & Joint Inst Chicago, IL - 60625

Illinois Bone & Joint Inst is categorized under Medical Groups in Chicago, IL .

Illinois Bone & Joint Inst was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Medical Groups business, which does work in the B2C market, and is classified as a Medical Groups, under code number 6219993 by the NAICS.

If you are seeking more information, feel free to contact Michelle Flaherty, Office Manager at the company’s single location by writing to 2740 West Foster Avenue # 301, Chicago, Illinois IL 60625 or by phoning (773) 561-2600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Illinois Bone & Joint Inst
Contact Person: Michelle Flaherty, Office Manager
Address: 2740 West Foster Avenue # 301, Chicago, Illinois 60625
Phone Number: (773) 561-2600
Website Address: ibji.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Groups
SIC Code: 8099
NAICS Code: 6219993
Share This Business:

Illinois Bone & Joint Inst was started in 0 to provide professional Medical Groups under the SIC code 8099 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Michelle Flaherty, Office Manager for inquiries that concern Illinois Bone & Joint Inst by calling the company number (773) 561-2600, as your correspondence is most welcome. Additionally, the physical location of the single location of Illinois Bone & Joint Inst can be found at the coordinates 41.975886,-87.697493 as well as the street address 2740 West Foster Avenue # 301 in Chicago, Illinois 60625.

For its online presence, you may visit Illinois Bone & Joint Inst’s website at ibji.com and engage with its social media outlets through on Twitter and on Facebook.